EHC vs SGRY โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EHC Captures Institutional Edge (2โ2 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Encompass Health Corporation Common Stock (EHC) driven by superior Valuation, Growth & Margin while SGRY counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, EHC trades at 19.4x Forward P/E with 18.4% operating margin (+8.9% YoY revenue) versus SGRY at N/M Forward P/E and 13.2% operating margin (-0.8% YoY). In options structure, EHC sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro) against SGRY sits in SURGE (34th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | EHC Revenue | SGRY Revenue | EHC Op. Margin | SGRY Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $4.28B | $1.77B | 13.0% | 4.4% | EHC |
| FY2019 | $4.61B | $1.83B | 13.3% | 12.9% | EHC |
| FY2020 | $3.57B | $1.86B | 15.8% | 9.8% | EHC |
| FY2021 | $4.01B | $2.23B | 13.9% | 13.6% | EHC |
| FY2022 | $4.35B | $2.54B | 12.4% | 13.6% | SGRY |
| FY2023 | $4.80B | $2.74B | 7.3% | 12.0% | SGRY |
| FY2024 | $5.37B | $3.11B | 8.5% | 11.2% | SGRY |
| FY2025 | $5.94B | $3.31B | 9.5% | 11.8% | SGRY |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EHC | SGRY | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $13.0B | $3.5B | Larger Scale | EHC |
| Trailing P/E Ratio Valuation | 21.2x | N/M | Lower Multiple | EHC |
| Forward P/E Ratio Valuation | 19.4x | N/M | Lower Multiple | EHC |
| Revenue Growth (YoY) Growth | +8.9% | -0.8% | Higher Growth | EHC |
| Operating Margin (TTM) Profitability | 18.4% | 13.2% | Higher Margin | EHC |
| Net Profit Margin Profitability | 10.2% | -2.6% | Higher Margin | EHC |
| Return on Equity (ROE) Capital Efficiency | 25.1% | 2.1% | Higher ROE | EHC |
| 52-Week Range Position Momentum | 80% ($93โ$144) | 97% ($11โ$27) | Stronger Trend | SGRY |
| Beta / 30D Volatility Risk Regime | -0.10ฮฒ ยท 40% Vol | 0.87ฮฒ ยท 166% Vol | Lower Realized Risk | EHC |
| Unified Institutional Score Composite Signal | 52.0 / 100 (HOLD) | 29.6 / 100 (SELL) | Higher Composite | EHC |